Ancora Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $830K | Sell |
1,655
-541
| -25% | -$260K | 0.02% | 455 |
|
|
2026
Q1 | $1.08M | Sell |
2,196
-15
| -0.7% | -$8.14K | 0.02% | 388 |
|
|
2025
Q4 | $1.28M | Buy |
2,211
+665
| +43% | +$376K | 0.03% | 362 |
|
|
2025
Q3 | $750K | Buy |
1,546
+126
| +9% | +$58.6K | 0.02% | 471 |
|
|
2025
Q2 | $576K | Buy |
1,420
+244
| +21% | +$102K | 0.01% | 504 |
|
|
2025
Q1 | $585K | Sell |
1,176
-78
| -6% | -$42.2K | 0.01% | 488 |
|
|
2024
Q4 | $652K | Buy |
1,254
+61
| +5% | +$33.5K | 0.01% | 469 |
|
|
2024
Q3 | $738K | Buy |
1,193
+61
| +5% | +$36.1K | 0.02% | 444 |
|
|
2024
Q2 | $626K | Sell |
1,132
-62
| -5% | -$35.5K | 0.02% | 463 |
|
|
2024
Q1 | $694K | Sell |
1,194
-25
| -2% | -$14K | 0.02% | 452 |
|
|
2023
Q4 | $647K | Buy |
1,219
+115
| +10% | +$55.7K | 0.02% | 457 |
|
|
2023
Q3 | $559K | Sell |
1,104
-214
| -16% | -$114K | 0.01% | 452 |
|
|
2023
Q2 | $688K | Buy |
1,318
+240
| +22% | +$130K | 0.02% | 409 |
|
|
2023
Q1 | $621K | Sell |
1,078
-17
| -2% | -$9.58K | 0.02% | 425 |
|
|
2022
Q4 | $603K | Sell |
1,095
-217
| -17% | -$115K | 0.02% | 448 |
|
|
2022
Q3 | $665K | Sell |
1,312
-35
| -3% | -$19.6K | 0.02% | 447 |
|
|
2022
Q2 | $732K | Sell |
1,347
-138
| -9% | -$76K | 0.02% | 436 |
|
|
2022
Q1 | $877K | Buy |
1,485
+81
| +6% | +$46.5K | 0.02% | 412 |
|
|
2021
Q4 | $936K | Buy |
1,404
+638
| +83% | +$398K | 0.02% | 392 |
|
|
2021
Q3 | $438K | Buy |
766
+95
| +14% | +$52.1K | 0.01% | 578 |
|
|
2021
Q2 | $339K | Sell |
671
-7
| -1% | -$3.3K | 0.01% | 637 |
|
|
2021
Q1 | $309K | Buy |
678
+12
| +2% | +$5.73K | 0.01% | 630 |
|
|
2020
Q4 | $310K | Buy |
666
+10
| +2% | +$4.69K | 0.01% | 555 |
|
|
2020
Q3 | $289K | Buy |
656
+80
| +14% | +$33.1K | 0.01% | 540 |
|
|
2020
Q2 | $209K | Buy |
576
+98
| +21% | +$32.8K | 0.01% | 580 |
|
|
2020
Q1 | $136K | Hold |
478
| – | – | 0.01% | 717 |
|
|
2019
Q4 | $156K | Buy |
+478
| New | +$145K | 0.01% | 700 |
|
|
2019
Q2 | – | Sell |
-827
| Closed | -$226K | – | 621 |
|
|
2019
Q1 | $226K | Buy |
+827
| New | +$206K | 0.01% | 545 |
|
|
2018
Q4 | – | Sell |
-678
| Closed | -$166K | – | 1135 |
|
|
2018
Q3 | $166K | Buy |
+678
| New | +$156K | 0.01% | 674 |
|
|
2017
Q3 | – | Sell |
-1,150
| Closed | -$201K | – | 675 |
|
|
2017
Q2 | $201K | Buy |
+1,150
| New | +$193K | 0.01% | 587 |
|
|
2017
Q1 | – | Sell |
-1,250
| Closed | -$176K | – | 1034 |
|
|
2016
Q4 | $176K | Buy |
+1,250
| New | +$184K | 0.01% | 575 |
|
|
2015
Q1 | – | Sell |
-2,000
| Closed | -$258K | – | 416 |
|
|
2014
Q4 | $251K | Hold |
2,000
| – | – | 0.03% | 416 |
|
|
2014
Q3 | $243K | Sell |
2,000
-500
| -20% | -$60.8K | 0.03% | 397 |
|
|
2014
Q2 | $295K | Hold |
2,500
| – | – | 0.04% | 391 |
|
|
2014
Q1 | $301K | Hold |
2,500
| – | – | 0.04% | 357 |
|
|
2013
Q4 | $278K | Sell |
2,500
-500
| -17% | -$49.7K | 0.04% | 338 |
|
|
2013
Q3 | $276K | Hold |
3,000
| – | – | 0.05% | 324 |
|
|
2013
Q2 | $254K | Buy |
+3,000
| New | +$250K | 0.04% | 339 |
|
Other funds holding TMO
Ancora Advisors's TMO Position: Q2 2026 in Review
Ancora Advisors reduced its Thermo Fisher Scientific (TMO) stake by 25% in Q2 2026, selling an estimated $260K and leaving 1,655 shares worth $830K. The position accounts for 0.02% of the portfolio, ranked #455.
Ancora Advisors first reported a position in TMO in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.28M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Ancora Advisors held 1,655 shares of Thermo Fisher Scientific worth $830K as of Q2 2026.
- Ancora Advisors sold 541 Thermo Fisher Scientific shares in Q2 2026, an estimated $260K.
- Thermo Fisher Scientific made up 0.02% of Ancora Advisors's portfolio in Q2 2026, its #455 holding.
- Ancora Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 38 quarters since.
- Ancora Advisors's Thermo Fisher Scientific position peaked at $1.28M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.